Skip to content

RECTAL DICLOFENAC VERSUS INTRAMUSCULAR DICLOFENAC FOR POST OPERATIVE ANALGESIA AFTER MYOMECTOMY: A RANDOMISED STUDY

RECTAL DICLOFENAC VERSUS INTRAMUSCULAR DICLOFENAC FOR POST OPERATIVE ANALGESIA AFTER MYOMECTOMY: A RANDOMISED STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202206556144219
Enrollment
90
Registered
2022-06-10
Start date
2022-06-06
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post operative pain management following Myomectomy

Interventions

Suppository Rectal Diclofenac group

Sponsors

Dr Chiadikobi John Irechukwu
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Participants willingness to participate in the study

Exclusion criteria

Exclusion criteria: 1. Women that declined consent 2. Women with significant diseases like rectal disorders, peptic ulcer disease, hepatic,hematological and cardiovascular diseases.3. History of chronic pain 4. History of bleeding coagulopathies 5. Use of general anaesthesia 6. Adverse reaction or hypersensitivity to diclofenac or pentazocine

Design outcomes

Primary

MeasureTime frame
The primary outcome will be the pain score assessed using the visual analogue scale.

Secondary

MeasureTime frame
The secondary outcome measures will be patients’ satisfaction which will be assessed after 24 hours of administration of the drugs, the need and frequency of rescue analgesia and maternal side effects

Countries

Nigeria

Contacts

Public ContactGeorge Eleje

Consultant Obstetrician and Gynaecologist Department of Obstetrics and Gynaecology Nnamdi Azikiwe University Teaching Hospital Nnewi Nigeria

georgel21@yahoo.com+2348068117444

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026